The JAX-NYSCF Global Stem Cell Array®
Automated stem cell reprogramming, genome editing, and differentiation
JAX–NYSCF is driving innovation in stem cell science through a comprehensive, end-to-end platform that converts cutting-edge technology into scalable processes. By producing high-quality induced pluripotent stem cell (iPSC) lines and differentiating them into diverse, disease-relevant cell types, the Global Stem Cell Array enables deeper insights into human biology and disease. Advanced capabilities for fully automated, high-throughput cell culture systems, traceable workflows, and robust project management support efficient and reproducible research.
Complemented by expertise in genome editing, stem cell phenotypic assay development, high-content imaging, and AI-enabled compound screening, the platform will enable researchers to uncover the mechanisms underlying a wide range of diseases and accelerate therapeutic discovery.
Advanced Technology for Stem Cell Derivation,
Differentiation & Genome Editing
•
Differentiation of iPSCs into major brain cell types (neurons and glia), hepatocytes, pancreatic beta cells/organoids, cardiomyocytes, retinal pigmented epithelia, immune cells, and neural progenitors/organoids
•
Fully automated reprogramming with highly reproducible production and massively parallel sample processing eliminating manual manipulation and minimizing line-to-line variability
•
Automated genome editing for production of isogenic control lines and generation of CRISPR/Cas9 knockouts
•
Delivered with stringent quality control, advanced tracking and data management, and comprehensive Certificate of Analysis reporting
Speak to an Expert
Copyright © 2026, The Jackson Laboratory, All rights reserved.